Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01761110 · ClinicalTrials.gov registry record · NA
Pilot Test of a Community-based Buprenorphine Treatment Intervention
A NA study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT01761110 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 77 participants.
The verdict
NCT01761110, a NA study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
The main goal of this study is to pilot test the community-based buprenorphine treatment (CBBT) intervention, examining buprenorphine treatment initiation, opioid use, and HIV risk behaviors. Two groups of participants will be followed for 60 days, with 3 research visits. One group will be enrolled prior to the CBBT intervention (pre-intervention), and one group after the CBBT intervention (post-intervention). Data sources will include questionnaires, urine toxicology tests, and medical record data. Investigators hypothesize that compared to the participants in the pre-intervention group, participants in the post-intervention group will be more likely to initiate buprenorphine treatment, reduce opioid use, and reduce high-risk HIV risk behaviors.
Interventions
- BEHAVIORAL Community-based buprenorphine treatment (CBBT) intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01761110
The ClinicalTrials.gov registry entry for NCT01761110 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Community-based buprenorphine treatment (CBBT) intervention is the first listed.
NCT01761110 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01761110 about?
NCT01761110 is a clinical study titled "Pilot Test of a Community-based Buprenorphine Treatment Intervention". The main goal of this study is to pilot test the community-based buprenorphine treatment (CBBT) intervention, examining buprenorphine treatment initiation, opioid use, and HIV risk behaviors. Two groups of participants will be followed for 60 days, with 3 research visits. One group will be enrolled ...
What is the current status of trial NCT01761110?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2012-12. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01761110?
The interventions under investigation include: Community-based buprenorphine treatment (CBBT) intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01761110?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.